(Q40856171)

24 September 2017

1 reference

title

The future use of complement inhibitors for the treatment of neurological diseases (English)

1 reference

24 September 2017

McGeer EG

1

1 reference

PubMed ID

9617589

24 September 2017

McGeer PL

series ordinal

2

1 reference

24 September 2017

1 June 1998

1 reference

24 September 2017

1 reference

24 September 2017

55

1 reference

24 September 2017

6

1 reference

24 September 2017

739-746

1 reference

https://scigraph.springernature.com/pub.10.2165/00003495-199855060-00001

24 September 2017

0 references

cites work

Pharmacological treatment strategies in age-related cataracts

1 reference

12 December 2020

Initial cyclosporin A but not glucocorticoid treatment promotes recovery of striatal dopamine concentration in 6-hydroxydopamine lesioned mice.

1 reference

12 December 2020

Chromogranin A triggers a phenotypic transformation and the generation of nitric oxide in brain microglial cells

1 reference

12 December 2020

Cardioprotective effects of a C1 esterase inhibitor in myocardial ischemia and reperfusion

1 reference

12 December 2020

The role of the immune system in neurodegenerative disorders

1 reference

12 December 2020

Neurons express proteins of the classical complement pathway in Alzheimer disease.

1 reference

12 December 2020

Cyclosporin A protects against ischemia-reperfusion injury in the brain

1 reference

12 December 2020

Cyclosporin A attenuates the decrease in tyrosine hydroxylase immunoreactivity in nigrostriatal dopaminergic neurons and in striatal dopamine content in rats with intrastriatal injection of 6-hydroxydopamine.

1 reference

12 December 2020

LU 51198, a highly sulfated, low-molecular-weight heparin derivative, prevents complement-mediated myocardial injury in the perfused rabbit heart.

1 reference

12 December 2020

A soluble chimeric complement inhibitory protein that possesses both decay-accelerating and factor I cofactor activities

1 reference

12 December 2020

Inhibitory effect of FUT-175 on complement activation and its application for glomerulonephritis with hypocomplementemia

1 reference

12 December 2020

Xenogeneic orthotopic liver transplantation from sheep to pig: delay of rejection by FUT 175 Infusion

1 reference

12 December 2020

The SC5b-7 complex: formation, isolation, properties, and subunit composition

1 reference

12 December 2020

Suppressive effect of FK-506, a novel immunosuppressant, against MPTP-induced dopamine depletion in the striatum of young C57BL/6 mice.

1 reference

12 December 2020

SP-40,40 is an inhibitor of C5b-6-initiated haemolysis

1 reference

12 December 2020

Complement activation and inhibition in myocardial ischemia and reperfusion injury

1 reference

12 December 2020

Therapeutic uses of recombinant complement protein inhibitors

1 reference

12 December 2020

Cyclosporin A prevents ischemia-induced reduction of muscarinic acetylcholine receptors with suppression of microglial activation in gerbil hippocampus

1 reference

12 December 2020

Molecular structure and functional characterization of a human complement cytolysis inhibitor found in blood and seminal plasma: identity to sulfated glycoprotein 2, a constituent of rat testis fluid

1 reference

12 December 2020

Protective effects of soluble CR1 in complement- and neutrophil-mediated tissue injury

1 reference

12 December 2020

Clinical complementology: recent progress and future trends

1 reference

12 December 2020

Anti-C5 monoclonal antibody therapy prevents collagen-induced arthritis and ameliorates established disease

1 reference

12 December 2020

Controlling the complement system in inflammation

1 reference

12 December 2020

The preventive effect of cyclosporin A, an immunosuppressant, on the late onset reduction of muscarinic acetylcholine receptors in gerbil hippocampus after transient forebrain ischemia.

1 reference

12 December 2020

Prolonging discordant xenograft survival with anticomplement reagents K76COOH and FUT175

1 reference

12 December 2020

The regulators of complement activation (RCA) gene cluster

1 reference

12 December 2020

CD59 expression and complement susceptibility of human neuronal cell line (NTera2).

1 reference

12 December 2020

Transgenic pigs expressing human CD59 and decay-accelerating factor produce an intrinsic barrier to complement-mediated damage

1 reference

12 December 2020

Ketoprofen, a non-steroidal anti-inflammatory drug prevents the late-onset reduction of muscarinic receptors in gerbil hippocampus after transient forebrain ischemia.

1 reference

12 December 2020

Low-dose aspirin therapy for chronic stable angina. A randomized, placebo-controlled clinical trial.

1 reference

12 December 2020

Inhibition of complement dependent experimental inflammation in human skin by different heparin fractions

1 reference

12 December 2020

Activation of macrophages by Alzheimer beta amyloid peptide.

1 reference

12 December 2020

Protective effects of selectin chimeras in neutrophil-mediated lung injury.

1 reference

12 December 2020

Clinical trial of indomethacin in Alzheimer's disease.

1 reference

12 December 2020

Membrane proteins that protect against complement lysis

1 reference

12 December 2020

Antiplatelet therapy in the prevention of ischaemic stroke

1 reference

12 December 2020

Hippocampal damage associated with prolonged glucocorticoid exposure in primates

1 reference

12 December 2020

Organization of the genes encoding complement receptors type 1 and 2, decay-accelerating factor, and C4-binding protein in the RCA locus on human chromosome 1.

1 reference

12 December 2020

A serum protein SP40,40 modulates the formation of membrane attack complex of complement on erythrocytes

1 reference

12 December 2020

Rheumatoid arthritis, aspirin, and gastrointestinal cancer

1 reference

12 December 2020

Complement inhibitory therapeutics and xenotransplantation

1 reference

12 December 2020

Cyclosporin A attenuates degeneration of dopaminergic neurons induced by 6-hydroxydopamine in the mouse brain.

1 reference

12 December 2020

Local extrahepatic expression of complement genes C3, factor B, C2, and C4 is increased in murine lupus nephritis

1 reference

12 December 2020

Inhibition of complement-mediated cytolysis by the terminal complement inhibitor of herpesvirus saimiri.

1 reference

12 December 2020

Stroke prevention in women: Role of aspirin versus ticlopidine

1 reference

12 December 2020

Structure, organization, and regulation of the complement genes

1 reference

12 December 2020

Engineering of recombinant soluble CD46: an inhibitor of complement activation

1 reference

12 December 2020

Nonsteroidal antiinflammatory drugs and breast cancer

1 reference

12 December 2020

The inflammatory response system of brain: implications for therapy of Alzheimer and other neurodegenerative diseases

1 reference

12 December 2020

Neuronal expression of mRNAs for complement proteins of the classical pathway in Alzheimer brain.

1 reference

12 December 2020

Thalidomide reduces MPTP-induced decrease in striatal dopamine levels in mice.

1 reference

12 December 2020

Soluble human complement receptor type 1: in vivo inhibitor of complement suppressing post-ischemic myocardial inflammation and necrosis

1 reference

12 December 2020

Decay-accelerating factor. Genetic polymorphism and linkage to the RCA (regulator of complement activation) gene cluster in humans

1 reference

12 December 2020

A sialyl Lewis(x)-containing carbohydrate reduces infarct size: role of selectins in myocardial reperfusion injury

1 reference

12 December 2020

Inhibition of complement, evoked antibody, and cellular response prevents rejection of pig-to-primate cardiac xenografts

1 reference

12 December 2020

Amelioration by cyclosporin A of brain damage following 5 or 10 min of ischemia in rats subjected to preischemic hyperglycemia.

1 reference

12 December 2020

Physiology and pathophysiology of complement: progress and trends.

1 reference

12 December 2020

Control of the complement system.

1 reference

12 December 2020

Arthritis and anti-inflammatory agents as possible protective factors for Alzheimer's disease: a review of 17 epidemiologic studies

1 reference

12 December 2020

Inhibition of homologous complement by CD59 is mediated by a species-selective recognition conferred through binding to C8 within C5b-8 or C9 within C5b-9.

1 reference

12 December 2020

10.2165/00003495-199855060-00001

Identifiers

DOI

1 reference

PubMed ID

9617589

Dimensions Publication ID

24 September 2017

0 references

1 reference

PubMed ID

9617589